Brief: Talaris Therapeutics Declares Special Dividend In Connection With Proposed Merger With Tourmaline Bio
06/10/2023 22:19
Oct 6 (Reuters) - Talaris Therapeutics Inc TALS.O :
* TALARIS THERAPEUTICS DECLARES SPECIAL DIVIDEND IN
CONNECTION
WITH PROPOSED MERGER WITH TOURMALINE BIO
* TALARIS THERAPEUTICS INC: SPECIAL DIVIDEND ESTIMATED TO BE
$1.5118 PER SHARE
Source text for Eikon: ID:nGNX3gC4t7
Further company coverage: TALS.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy